Medicine guide

Xolair 150 mg/1.0 ml

As listed in the register: Xolair 150 mg/1.0 ml, Injektionslösung in einem Fertigpen

150 mg/1.0 ml ·

  • Prescription only
  • Breathing, airways, allergies and cough
Active substance
Omalizumabum
Made by
Novartis Pharma Schweiz AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Allergisches Asthma, chronische spontane Urtikaria, Nasenpolypen

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byNovartis Pharma Schweiz AG
Active substanceOmalizumabum
Used inBreathing, airways, allergies and cough
Strength150 mg/1.0 ml
ClassificationR03DX05 · Breathing, airways, allergies and cough
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerXolair 150 mg/1.0 ml, Injektionslösung in einem Fertigpen
Packs1 Injektor(en), vorgefüllt/Pen
Zulassungsnummer69272
Dosisstärke2

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.